DOCSLIB.ORG

Specific Oxylipins Enhance Vertebrate Hematopoiesis Via the Receptor GPR132

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Specific Oxylipins Enhance Vertebrate Hematopoiesis Via the Receptor GPR132 Specific oxylipins enhance vertebrate hematopoiesis via the receptor GPR132 Jamie L. Lahvica,b, Michelle Ammermana,b, Pulin Lia,b, Megan C. Blaira,b, Emma R. Stillmana,b, Eva M. Fastc,d, Anne L. Robertsona,b, Constantina Christodouloua,b, Julie R. Perlina,b, Song Yanga,b, Nan Chiange, Paul C. Norrise, Madeleine L. Dailya,b, Shelby E. Redfielda,b, Iris T. Chana,b, Mona Chatrizeha,b, Michael E. Chasea,b, Olivia Weisa,b, Yi Zhoua,b, Charles N. Serhane, and Leonard I. Zona,b,c,d,f,1 aStem Cell Program, Boston Children’s Hospital, Boston, MA 02115; bDivision of Hematology/Oncology, Boston Children’s Hospital, Boston, MA 02115; cHarvard Stem Cell Institute, Harvard University, Cambridge, MA 02138; dDepartment of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138; eCenter for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital, Boston, MA 02115; and fHoward Hughes Medical Institute, Boston Children’s Hospital, Boston, MA 02115 Edited by Gregg L. Semenza, Johns Hopkins University School of Medicine, Baltimore, MD, and approved July 30, 2018 (received for review April 11, 2018) Epoxyeicosatrienoic acids (EETs) are lipid-derived signaling mole- require G protein signaling components to elicit many phenotypes cules with cardioprotective and vasodilatory actions. We recently (10–12). For instance, we previously showed that EET’sen- showed that 11,12-EET enhances hematopoietic induction and hancement of zebrafish hematopoiesis requires signaling via engraftment in mice and zebrafish. EETs are known to signal via G Gα12/13 (5). protein-coupled receptors, with evidence supporting the existence As traditional biochemical methods have so far failed to of a specific high-affinity receptor. Identification of a hematopoietic- identify EET receptors, here we used bioinformatic techniques specific EET receptor would enable genetic interrogation of EET to identify candidate receptors and assayed those candidates for signaling pathways, and perhaps clinical use of this molecule. We EET responsiveness in vitro. Only GPR132 (G2A), a previously developed a bioinformatic approach to identify an EET receptor described fatty acid receptor (13–16), showed responsiveness to based on the expression of G protein-coupled receptors in cell lines EET. We demonstrated that GPR132 is required for EET- with differential responses to EETs. We found 10 candidate EET induced hematopoietic stem cell specification in the zebrafish BIOLOGY receptors that are expressed in three EET-responsive cell lines, but and for normal hematopoietic stem cell transplant in the mouse. DEVELOPMENTAL not expressed in an EET-unresponsive line. Of these, only recombinant Previously described fatty acid activators of GPR132 induced GPR132 showed EET-responsiveness in vitro, using a luminescence- hematopoietic phenotypes in the zebrafish essentially identical to based β-arrestin recruitment assay. Knockdown of zebrafish gpr132b those observed with EET, further confirming that these molecules prevented EET-induced hematopoiesis, and marrow from GPR132 activate the same pathway. We performed structure–activity re- knockout mice showed decreased long-term engraftment capability. lationship analyses to determine the full range of GPR132 acti- In contrast to high-affinity EET receptors, GPR132 is reported to re- vators. Rather than a regiospecific, high-affinity receptor, our data spond to additional hydroxy-fatty acids in vitro, and we found that show that GPR132 is likely a low-affinity, promiscuous receptor these same hydroxy-fatty acids enhance hematopoiesis in the zebra- for a select panel of oxygenated polyunsaturated fatty acids, whose fish. We conducted structure–activity relationship analyses using both activity drives hematopoiesis in embryonic and adult vertebrate cell culture and zebrafish assays on diverse medium-chain fatty acids. contexts. Certain oxygenated, unsaturated free fatty acids showed high activa- tion of GPR132, whereas unoxygenated or saturated fatty acids had Significance lower activity. Absence of the carbon-1 position carboxylic acid pre- vented activity, suggesting that this moiety is required for receptor Small-molecule enhancers of hematopoietic stem cell trans- activation. GPR132 responds to a select panel of oxygenated polyunsat- plant could improve the safety of this treatment and expand urated fatty acids to enhance both embryonic and adult hematopoiesis. the pool of eligible patients. We previously showed that the lipid 11,12-epoxyeicosatrienoic acid (EET) enhanced transplant hematopoiesis | free fatty acid | GPCR | zebrafish in zebrafish and mice. We use a bioinformatic approach to identify candidate EET receptors and demonstrate that EET icosanoids are endogenous bioactive mediators derived from activates GPR132. We find that this receptor is important in Earachidonic acid, and are responsible for a variety of physi- zebrafish and mouse hematopoiesis, and we further show that ological phenotypes (1). Epoxyeicosatrienoic acids (EETs), a GPR132 has responsiveness to additional oxygenated poly- major class of eicosanoids formed by cytochrome P450 enzymes, unsaturated fatty acids such as EET. Thus, GPR132 receives play critical roles in endothelial migration, monocyte adhesion, lipid-derived signals to regulate hematopoiesis and is a thera- tumor metastasis, and vasodilation, among other cell-type- peutic target for enhancing HSC transplant. specific effects (2–4). We recently showed that 11,12-EET enhances the specification of hematopoietic stem and progenitor Author contributions: J.L.L., P.L., J.R.P., N.C., Y.Z., C.N.S., and L.I.Z. designed research; cells (HSPCs) in developing zebrafish embryos, as well as the J.L.L., M.A., P.L., M.C.B., E.R.S., E.M.F., A.L.R., C.C., J.R.P., N.C., P.C.N., M.L.D., S.E.R., transplant of HSPCs in both fish and mice (5). Despite the im- I.T.C., M.C., M.E.C., and O.W. performed research; J.L.L., E.M.F., C.C., S.Y., C.N.S., and portant physiological roles of EETs, their direct protein target(s) L.I.Z. analyzed data; and J.L.L., P.L., E.M.F., C.N.S., and L.I.Z. wrote the paper. remain unknown. The authors declare no conflict of interest. Previous results indicate that EETs bind to at least one spe- This article is a PNAS Direct Submission. cific G protein-coupled receptor (GPCR). Nanomolar or even Published under the PNAS license. picomolar concentrations of 11,12- or 14,15-EET can elicit spe- Data deposition: The data reported in this paper have been deposited in the Gene Ex- cific cellular phenotypes (6, 7), and a bead-tethered EET without pression Omnibus (GEO) database, https://www.ncbi.nlm.nih.gov/geo (accession no. the ability to cross the plasma membrane maintained its activity GSE113550). (8), suggesting the existence of a high-affinity, membrane-bound 1To whom correspondence should be addressed. Email: [email protected]. EET receptor. Chen et al. (9) demonstrated that U937 and other This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. EET-responsive cell lines express a single high-affinity EET re- 1073/pnas.1806077115/-/DCSupplemental. ceptor of about 47 kDa in size. This is likely a GPCR, as EETs www.pnas.org/cgi/doi/10.1073/pnas.1806077115 PNAS Latest Articles | 1of6 Downloaded by guest on September 24, 2021 Results A B Identification of Candidate EET Receptors. EETs elicit phenotypes 5 GPR132 ce 11,12-EET only in specific cell types, suggesting that a putative EET re- 4 14,15-EET b-arrestin PGE2 ceptor might be selectively expressed in these cell types. We gal b-gal 3 performed RNAseq profiling in duplicate on three previously minescen 2 b-arrestin Lu b- identified EET-responsive human cell lines [U937 monocytes (17), e 1 EaHy endothelial cells (18), and PC3M-LN4 prostate cancer cells liligandgand GPCRGPCR lativ e 0 (4)], two of which show binding to a radiolabeled EET analog (9). R -9 -8 -7 -6 -5 -4 -3 We profiled a fourth cell line (HEK293) that has no known re- Ligand Conc (log10M) C D sponsiveness to EET and shows no such binding (9). Although we ADRB2 10 HRH1 20 ce detected reads for hundreds of GPCRs (SI Appendix, Fig. S1), only Isoproterenol Histamine 37 GPCRs were expressed in common in all three EET-responsive 11,12-EET 8 11,12-EET 15 14,15-EET 14,15-EET nescence cell lines above 0.3 fragments per kilobase per million reads i 6 10 minescen (FPKM) (SI Appendix,Fig.S2A), a conservative threshold for 4 Lu physiologically meaningful abundance. Of these, 27 were also e 5 2 expressed at moderate to high levels (FPKM > 0.9) in our EET 0 0 Relativ nonbinding cell line (SI Appendix,Fig.S2B). This left 10 candidate Relative Lum -10 -8 -6 -4 -2 -10 -8 -6 -4 -2 EET receptors that were expressed only in EET binding cell lines Ligand Conc (log10M) Ligand Conc (log10M) and were missing from the nonbinding cell line. All candidates had E PTGER2 F PTGER4 8 e 6 predicted molecular weights within 20% of the predicted 47-kDa PGE2 PGE2 size of an EET receptor (9), and candidates included both well- 11,12-EET 5 11,12-EET 6 scenc β 4 studied GPCRs such as the -adrenergic receptor and prosta- ne 4 3 glandin receptors and orphan GPCRs such as GPR132 and umi L 2 GPR135 (SI Appendix,Fig.S2C). 2 ive t 1 a 0 0 Relative Luminescence β Rel EET Activates -Arrestin Recruitment via GPR132 in Vitro. GPCR -10 -8 -6 -4 -2 -10 -8 -6 -4 -2 activation causes recruitment of β-arrestin, which can be mea- Ligand Conc (log10M) Ligand Conc (log10M) sured with the luminescence-based PathHunter assay (13, 15, G H e 4 CCRL2 5 GPR135 19). We tested for EET-induced β-arrestin recruitment via each 11,12-EET nc Chemerin e MIP-3beta ence 14,15-EET candidate GPCR with the exception of GPR68, PTGER1, and c 4 3 11,12-EET nes i 3 LPAR6, which have no available PathHunter assays (Fig.
Load more

Recommended publications
  • Edinburgh Research Explorer
    Edinburgh Research Explorer International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list Citation for published version: Davenport, AP, Alexander, SPH, Sharman, JL, Pawson, AJ, Benson, HE, Monaghan, AE, Liew, WC, Mpamhanga, CP, Bonner, TI, Neubig, RR, Pin, JP, Spedding, M & Harmar, AJ 2013, 'International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands', Pharmacological reviews, vol. 65, no. 3, pp. 967-86. https://doi.org/10.1124/pr.112.007179 Digital Object Identifier (DOI): 10.1124/pr.112.007179 Link: Link to publication record in Edinburgh Research Explorer Document Version: Publisher's PDF, also known as Version of record Published In: Pharmacological reviews Publisher Rights Statement: U.S. Government work not protected by U.S. copyright General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 02. Oct. 2021 1521-0081/65/3/967–986$25.00 http://dx.doi.org/10.1124/pr.112.007179 PHARMACOLOGICAL REVIEWS Pharmacol Rev 65:967–986, July 2013 U.S.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • G Protein-Coupled Receptors
    S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors. British Journal of Pharmacology (2015) 172, 5744–5869 THE CONCISE GUIDE TO PHARMACOLOGY 2015/16: G protein-coupled receptors Stephen PH Alexander1, Anthony P Davenport2, Eamonn Kelly3, Neil Marrion3, John A Peters4, Helen E Benson5, Elena Faccenda5, Adam J Pawson5, Joanna L Sharman5, Christopher Southan5, Jamie A Davies5 and CGTP Collaborators 1School of Biomedical Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK, 2Clinical Pharmacology Unit, University of Cambridge, Cambridge, CB2 0QQ, UK, 3School of Physiology and Pharmacology, University of Bristol, Bristol, BS8 1TD, UK, 4Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK, 5Centre for Integrative Physiology, University of Edinburgh, Edinburgh, EH8 9XD, UK Abstract The Concise Guide to PHARMACOLOGY 2015/16 provides concise overviews of the key properties of over 1750 human drug targets with their pharmacology, plus links to an open access knowledgebase of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. The full contents can be found at http://onlinelibrary.wiley.com/doi/ 10.1111/bph.13348/full. G protein-coupled receptors are one of the eight major pharmacological targets into which the Guide is divided, with the others being: ligand-gated ion channels, voltage-gated ion channels, other ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading.
    [Show full text]
  • 1 Supplemental Material Maresin 1 Activates LGR6 Receptor
    Supplemental Material Maresin 1 Activates LGR6 Receptor Promoting Phagocyte Immunoresolvent Functions Nan Chiang, Stephania Libreros, Paul C. Norris, Xavier de la Rosa, Charles N. Serhan Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA. 1 Supplemental Table 1. Screening of orphan GPCRs with MaR1 Vehicle Vehicle MaR1 MaR1 mean RLU > GPCR ID SD % Activity Mean RLU Mean RLU + 2 SD Mean RLU Vehicle mean RLU+2 SD? ADMR 930920 33283 997486.5381 863760 -7% BAI1 172580 18362 209304.1828 176160 2% BAI2 26390 1354 29097.71737 26240 -1% BAI3 18040 758 19555.07976 18460 2% CCRL2 15090 402 15893.6583 13840 -8% CMKLR2 30080 1744 33568.954 28240 -6% DARC 119110 4817 128743.8016 126260 6% EBI2 101200 6004 113207.8197 105640 4% GHSR1B 3940 203 4345.298244 3700 -6% GPR101 41740 1593 44926.97349 41580 0% GPR103 21413 1484 24381.25067 23920 12% NO GPR107 366800 11007 388814.4922 360020 -2% GPR12 77980 1563 81105.4653 76260 -2% GPR123 1485190 46446 1578081.986 1342640 -10% GPR132 860940 17473 895885.901 826560 -4% GPR135 18720 1656 22032.6827 17540 -6% GPR137 40973 2285 45544.0809 39140 -4% GPR139 438280 16736 471751.0542 413120 -6% GPR141 30180 2080 34339.2307 29020 -4% GPR142 105250 12089 129427.069 101020 -4% GPR143 89390 5260 99910.40557 89380 0% GPR146 16860 551 17961.75617 16240 -4% GPR148 6160 484 7128.848113 7520 22% YES GPR149 50140 934 52008.76073 49720 -1% GPR15 10110 1086 12282.67884
    [Show full text]
  • G Protein‐Coupled Receptors
    S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2019/20: G protein-coupled receptors. British Journal of Pharmacology (2019) 176, S21–S141 THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors Stephen PH Alexander1 , Arthur Christopoulos2 , Anthony P Davenport3 , Eamonn Kelly4, Alistair Mathie5 , John A Peters6 , Emma L Veale5 ,JaneFArmstrong7 , Elena Faccenda7 ,SimonDHarding7 ,AdamJPawson7 , Joanna L Sharman7 , Christopher Southan7 , Jamie A Davies7 and CGTP Collaborators 1School of Life Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK 2Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria 3052, Australia 3Clinical Pharmacology Unit, University of Cambridge, Cambridge, CB2 0QQ, UK 4School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK 5Medway School of Pharmacy, The Universities of Greenwich and Kent at Medway, Anson Building, Central Avenue, Chatham Maritime, Chatham, Kent, ME4 4TB, UK 6Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK 7Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK Abstract The Concise Guide to PHARMACOLOGY 2019/20 is the fourth in this series of biennial publications. The Concise Guide provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide represents approximately 400 pages, the material presented is substantially reduced compared to information and links presented on the website.
    [Show full text]
  • GPR135 (NM 022571) Human Tagged ORF Clone Lentiviral Particle Product Data
    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RC205463L3V GPR135 (NM_022571) Human Tagged ORF Clone Lentiviral Particle Product data: Product Type: Lentiviral Particles Product Name: GPR135 (NM_022571) Human Tagged ORF Clone Lentiviral Particle Symbol: GPR135 Synonyms: HUMNPIIY20 Vector: pLenti-C-Myc-DDK-P2A-Puro (PS100092) ACCN: NM_022571 ORF Size: 1482 bp ORF Nucleotide The ORF insert of this clone is exactly the same as(RC205463). Sequence: OTI Disclaimer: The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info OTI Annotation: This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. RefSeq: NM_022571.5 RefSeq Size: 1834 bp RefSeq ORF: 1485 bp Locus ID: 64582 UniProt ID: Q8IZ08 Protein Families: Druggable Genome, GPCR, Transmembrane MW: 51.6 kDa Gene Summary: Orphan receptor. Has spontaneous activity for beta-arrestin recruitment (PubMed:28827538). Shows a reciprocal regulatory interaction with the melatonin receptor MTNR1B most likely through receptor heteromerization (PubMed:28827538).[UniProtKB/Swiss-Prot Function] This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 1.
    [Show full text]
  • Expression Map of 78 Brain-Expressed Mouse Orphan Gpcrs Provides a Translational Resource for Neuropsychiatric Research
    ARTICLE DOI: 10.1038/s42003-018-0106-7 OPEN Expression map of 78 brain-expressed mouse orphan GPCRs provides a translational resource for neuropsychiatric research Aliza T. Ehrlich1,2, Grégoire Maroteaux2,5, Anne Robe1, Lydie Venteo3, Md. Taufiq Nasseef2, 1234567890():,; Leon C. van Kempen4,6, Naguib Mechawar2, Gustavo Turecki2, Emmanuel Darcq2 & Brigitte L. Kieffer 1,2 Orphan G-protein-coupled receptors (oGPCRs) possess untapped potential for drug dis- covery. In the brain, oGPCRs are generally expressed at low abundance and their function is understudied. Expression profiling is an essential step to position oGPCRs in brain function and disease, however public databases provide only partial information. Here, we fine-map expression of 78 brain-oGPCRs in the mouse, using customized probes in both standard and supersensitive in situ hybridization. Images are available at http://ogpcr-neuromap.douglas. qc.ca. This searchable database contains over 8000 coronal brain sections across 1350 slides, providing the first public mapping resource dedicated to oGPCRs. Analysis with public mouse (60 oGPCRs) and human (56 oGPCRs) genome-wide datasets identifies 25 oGPCRs with potential to address emotional and/or cognitive dimensions of psychiatric conditions. We probe their expression in postmortem human brains using nanoString, and included data in the resource. Correlating human with mouse datasets reveals excellent suitability of mouse models for oGPCRs in neuropsychiatric research. 1 IGBMC, Institut Génétique Biologie Moléculaire Cellulaire, Illkirch, France. 2 Douglas Mental Health University Institute and McGill University, Department of Psychiatry, Montreal, Canada. 3 Label Histologie, 51100 Reims, France. 4 Lady Davis Institute for Medical Research, Jewish General Hospital and McGill University, Department of Pathology, Montreal, Canada.
    [Show full text]
  • Adenylyl Cyclase 2 Selectively Regulates IL-6 Expression in Human Bronchial Smooth Muscle Cells Amy Sue Bogard University of Tennessee Health Science Center
    University of Tennessee Health Science Center UTHSC Digital Commons Theses and Dissertations (ETD) College of Graduate Health Sciences 12-2013 Adenylyl Cyclase 2 Selectively Regulates IL-6 Expression in Human Bronchial Smooth Muscle Cells Amy Sue Bogard University of Tennessee Health Science Center Follow this and additional works at: https://dc.uthsc.edu/dissertations Part of the Medical Cell Biology Commons, and the Medical Molecular Biology Commons Recommended Citation Bogard, Amy Sue , "Adenylyl Cyclase 2 Selectively Regulates IL-6 Expression in Human Bronchial Smooth Muscle Cells" (2013). Theses and Dissertations (ETD). Paper 330. http://dx.doi.org/10.21007/etd.cghs.2013.0029. This Dissertation is brought to you for free and open access by the College of Graduate Health Sciences at UTHSC Digital Commons. It has been accepted for inclusion in Theses and Dissertations (ETD) by an authorized administrator of UTHSC Digital Commons. For more information, please contact [email protected]. Adenylyl Cyclase 2 Selectively Regulates IL-6 Expression in Human Bronchial Smooth Muscle Cells Document Type Dissertation Degree Name Doctor of Philosophy (PhD) Program Biomedical Sciences Track Molecular Therapeutics and Cell Signaling Research Advisor Rennolds Ostrom, Ph.D. Committee Elizabeth Fitzpatrick, Ph.D. Edwards Park, Ph.D. Steven Tavalin, Ph.D. Christopher Waters, Ph.D. DOI 10.21007/etd.cghs.2013.0029 Comments Six month embargo expired June 2014 This dissertation is available at UTHSC Digital Commons: https://dc.uthsc.edu/dissertations/330 Adenylyl Cyclase 2 Selectively Regulates IL-6 Expression in Human Bronchial Smooth Muscle Cells A Dissertation Presented for The Graduate Studies Council The University of Tennessee Health Science Center In Partial Fulfillment Of the Requirements for the Degree Doctor of Philosophy From The University of Tennessee By Amy Sue Bogard December 2013 Copyright © 2013 by Amy Sue Bogard.
    [Show full text]
  • Two Neuroendocrine G Protein‐Coupled Receptor Molecules, Somatostatin and Melatonin: Physiology of Signal Transduction and Therapeutic Perspectives
    Received: 7 August 2020 | Revised: 4 September 2020 | Accepted: 10 September 2020 DOI: 10.1002/jcp.30062 REVIEW ARTICLE Two neuroendocrine G protein‐coupled receptor molecules, somatostatin and melatonin: Physiology of signal transduction and therapeutic perspectives Eva Costanzi1 | Carolina Simioni2,3 | Ilaria Conti1 | Ilaria Laface1 | Gabriele Varano1 | Cinzia Brenna1 | Luca M. Neri1,3 1Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Abstract Ferrara, Italy Recent studies have shown that G protein‐coupled receptors (GPCRs), the largest 2Department of Medical Sciences, University signal‐conveying receptor family, are targets for mutations occurring frequently in of Ferrara, Ferrara, Italy 3Laboratory for Technologies of Advanced different cancer types. GPCR alterations associated with cancer development re- Therapies (LTTA)‐Electron Microscopy present significant challenges for the discovery and the advancement of targeted Center, University of Ferrara, Ferrara, Italy therapeutics. Among the different molecules that can activate GPCRs, we focused Correspondence on two molecules that exert their biological actions regulating many typical features Luca M. Neri, Department of Morphology, of tumorigenesis such as cellular proliferation, survival, and invasion: somatostatin Surgery and Experimental Medicine, University of Ferrara, Via Fossato di Mortara and melatonin. The modulation of signaling pathways, that involves these two 70, Ferrara 44121, Italy. molecules, opens an interesting scenario for cancer therapy, with the opportunity to Email: [email protected] act at different molecular levels. Therefore, the aim of this review is the analysis of the biological activity and the therapeutic potential of somatostatin and melatonin, displaying a high affinity for GPCRs, that interfere with cancer development and maintenance. KEYWORDS GPCRs, melatonin, somatostatin, targeted therapies, tumors 1 | INTRODUCTION "G protein" identifies a complex of three proteins, named alpha, beta and gamma.
    [Show full text]
  • Orphan G Protein Coupled Receptors in Affective Disorders
    G C A T T A C G G C A T genes Review Orphan G Protein Coupled Receptors in Affective Disorders Lyndsay R. Watkins and Cesare Orlandi * Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, NY 14642, USA; [email protected] * Correspondence: [email protected] Received: 3 June 2020; Accepted: 21 June 2020; Published: 24 June 2020 Abstract: G protein coupled receptors (GPCRs) are the main mediators of signal transduction in the central nervous system. Therefore, it is not surprising that many GPCRs have long been investigated for their role in the development of anxiety and mood disorders, as well as in the mechanism of action of antidepressant therapies. Importantly, the endogenous ligands for a large group of GPCRs have not yet been identified and are therefore known as orphan GPCRs (oGPCRs). Nonetheless, growing evidence from animal studies, together with genome wide association studies (GWAS) and post-mortem transcriptomic analysis in patients, pointed at many oGPCRs as potential pharmacological targets. Among these discoveries, we summarize in this review how emotional behaviors are modulated by the following oGPCRs: ADGRB2 (BAI2), ADGRG1 (GPR56), GPR3, GPR26, GPR37, GPR50, GPR52, GPR61, GPR62, GPR88, GPR135, GPR158, and GPRC5B. Keywords: G protein coupled receptor (GPCR); G proteins; orphan GPCR (oGPCR); mood disorders; major depressive disorder (MDD); bipolar disorder (BPD); anxiety disorders; antidepressant; animal models 1. Introduction Mood alterations due to pharmacological treatments that modulate serotonergic and noradrenergic systems laid the foundations for the monoamine hypothesis that has led research on mood disorders since the late 1950s [1–3]. Dopaminergic alterations have also been associated with major depressive disorder (MDD) symptoms, such as anhedonia [4].
    [Show full text]
  • G Protein‐Coupled Receptors
    S.P.H. Alexander et al. The Concise Guide to PHARMACOLOGY 2019/20: G protein-coupled receptors. British Journal of Pharmacology (2019) 176, S21–S141 THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors Stephen PH Alexander1 , Arthur Christopoulos2 , Anthony P Davenport3 , Eamonn Kelly4, Alistair Mathie5 , John A Peters6 , Emma L Veale5 ,JaneFArmstrong7 , Elena Faccenda7 ,SimonDHarding7 ,AdamJPawson7 , Joanna L Sharman7 , Christopher Southan7 , Jamie A Davies7 and CGTP Collaborators 1School of Life Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK 2Monash Institute of Pharmaceutical Sciences and Department of Pharmacology, Monash University, Parkville, Victoria 3052, Australia 3Clinical Pharmacology Unit, University of Cambridge, Cambridge, CB2 0QQ, UK 4School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, UK 5Medway School of Pharmacy, The Universities of Greenwich and Kent at Medway, Anson Building, Central Avenue, Chatham Maritime, Chatham, Kent, ME4 4TB, UK 6Neuroscience Division, Medical Education Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK 7Centre for Discovery Brain Sciences, University of Edinburgh, Edinburgh, EH8 9XD, UK Abstract The Concise Guide to PHARMACOLOGY 2019/20 is the fourth in this series of biennial publications. The Concise Guide provides concise overviews of the key properties of nearly 1800 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide represents approximately 400 pages, the material presented is substantially reduced compared to information and links presented on the website.
    [Show full text]
  • LGR4 in BREAST CANCER STEM CELLS a Thesis by LI ZENG
    LGR4 IN BREAST CANCER STEM CELLS A Thesis by LI ZENG Submitted to the Office of Graduate and Professional Studies of Texas A&M University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Chair of Committee, Mingyao Liu Committee Members, Yi Li Fen Wang Yi Xu Dekai Zhang Head of Department, Van Wilson December 2014 Major Subject: Medical Sciences Copyright 2014 Li Zeng ABSTRACT Breast cancer is the most commonly diagnosed cancer among American women. G-protein coupled receptors (GPCR) comprise a huge family protein with almost 800 members. GPCRs sense molecules or other stimuli outside the cell, and activate intracellular signals. Consequently, a large proportion of modern drugs target these receptors. Lgr4 is a GPCR implicated in the development of multiple organs; in the mammary gland, it is expressed in the basal epithelial subpopulation and controls organ development by regulating stem cell activity through the wnt/β-catenin pathway. High breast tumor expression of Lgr4 correlated with a high risk of tumor relapse after chemokine therapy and an elevated risk of bone metastasis. We crossed mice bearing a gene trap cassette in the Lgr4 locus with several breast cancer mouse models such as MMTV-Wnt1 and MMTV-PyMT to study the consequences of Lgr4 expression ablation in breast cancer progression. We found that the absence of Lgr4 significantly delayed tumor progression in both MMTV-Wnt1 and MMTV-PyMT mouse models. Meanwhile, Lgr4 ablation led to diminished lung metastases in MMTV-PyMT tumors and several breast cancer cell lines. Further studies revealed that the repression of tumor progression and metastasis formation was due to a decreased cancer stem cell number in tumors with Lgr4 downregulation, as well as blocking of epithelial-mesenchymal transition.
    [Show full text]